ENTITY
Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) (2196 HK)

165
Analysis
Health CareChina
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical company. Through its subsidiaries, the Company manufactures genetic medicines, Chinese traditional medicines, diagnostic products, and medical instruments, provides technology, marketing, and advertising services, as well as invests in import and export trading.
more
bearishSisram Medical
07 Sep 2017 17:56

Sisram Medical IPO: Israeli Technology, China Story

Sisram Medical is raising up to USD174m in its Hong Kong listing. Sisram Medical is an Israel headquartered meditech company with backing from...

Logo
666 Views
Share
bearishMacroeconomics
24 Jul 2017 19:46

Money Matters: A Fish Called Wanda

Any analysis of China's credit growth over the past six years or so would suggest that it is unsustainable and that as a result, when the day of...

Share
16 May 2017 20:09

Fosun Pharma - Positive Sentiment from Acquisition Likely Priced in and Valuations Seem Stretched

Shanghai Fosun Pharmaceutical (Group) (2196 HK) is raising US$203 – 209m through issuing 55m primary shares with a 25m shares upsize option. The...

Share
05 May 2017 14:19

Consun Pharma 2016 FY: What's in the New Concoction?

Consun Pharma has managed to book a double-digit growth in revenue and earnings, 47.2% and 23.2% respectively; thanks to the sales growth of 13.8%...

Logo
503 Views
Share
09 Feb 2017 09:14

Trump Health Effect: What Is Next for the Consumer Health Industry Under Trump's Leadership?

While the US consumer health industry will remain a strong centre for investment, development and technology innovation in 2017 and is expected to...

Share
x